Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533.
N Engl J Med. 2016.
PMID: 26863353
Free article.
Clinical Trial.